Omeros (OMER) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.09% |
| Dec 31, 2025 | -10.19% |
| Sep 30, 2025 | 18.43% |
| Jun 30, 2025 | 7.48% |
| Mar 31, 2025 | -4.84% |
| Dec 31, 2024 | 5.80% |
| Sep 30, 2024 | 40.15% |
| Jun 30, 2024 | -51.55% |
| Mar 31, 2024 | 1.84% |
| Dec 31, 2023 | 17.42% |
| Sep 30, 2023 | -17.74% |
| Jun 30, 2023 | -14.52% |
| Mar 31, 2023 | 11.02% |
| Dec 31, 2022 | 20.94% |
| Sep 30, 2022 | -35.60% |
| Jun 30, 2022 | -6.83% |
| Mar 31, 2022 | 18.29% |
| Dec 31, 2021 | -7.69% |
| Sep 30, 2021 | 12.68% |
| Jun 30, 2021 | -0.71% |
| Mar 31, 2021 | -33.93% |
| Dec 31, 2020 | -32.99% |
| Sep 30, 2020 | 8.14% |
| Jun 30, 2020 | -16.91% |
| Mar 31, 2020 | 0.11% |
| Dec 31, 2019 | -113.53% |
| Sep 30, 2019 | -18.88% |
| Jun 30, 2019 | 51.46% |
| Mar 31, 2019 | -4.14% |
| Dec 31, 2018 | 47.88% |
| Sep 30, 2018 | -15.76% |
| Jun 30, 2018 | -10.57% |
| Mar 31, 2018 | -96.08% |
| Dec 31, 2017 | -176.34% |
| Sep 30, 2017 | 57.20% |
| Jun 30, 2017 | 6.18% |
| Mar 31, 2017 | -7.32% |
| Dec 31, 2016 | 1.50% |
| Sep 30, 2016 | -10.15% |
| Jun 30, 2016 | 43.82% |
| Mar 31, 2016 | -7.83% |
| Dec 31, 2015 | 6.53% |
| Sep 30, 2015 | -20.88% |
| Jun 30, 2015 | 10.95% |
| Mar 31, 2015 | 10.24% |
| Dec 31, 2014 | -16.59% |
| Sep 30, 2014 | 0.49% |
| Jun 30, 2014 | -9.77% |
| Mar 31, 2014 | -12.82% |
| Dec 31, 2013 | -3.48% |
| Sep 30, 2013 | -2.08% |
| Jun 30, 2013 | -31.34% |
| Mar 31, 2013 | -33.01% |
| Dec 31, 2012 | 42.21% |
| Sep 30, 2012 | -58.13% |
| Jun 30, 2012 | -2.13% |
| Mar 31, 2012 | 18.03% |
| Dec 31, 2011 | -59.75% |
| Sep 30, 2011 | -24.55% |
| Jun 30, 2011 | 23.27% |
| Mar 31, 2011 | 24.62% |
| Dec 31, 2010 | -14.25% |
| Sep 30, 2010 | 1.89% |